X0609 4 2026-09-02 0 0001689375 Entrada Therapeutics, Inc. TRDA 0001873392 Dowden Nathan J false C/O ENTRADA THERAPEUTICS, INC. ONE DESIGN CENTER PLACE, SUITE 17-500 BOSTON MA 02210 0 1 0 0 President & COO 0 Common Stock 2026-09-02 4 F 0 2528 7.1439 D 196060 D Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations. The sale does not represent a discretionary trade by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.97 to $7.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Jared Cohen, as Attorney-in-Fact 2026-09-03